-
1
-
-
10344263394
-
Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor
-
J.H. Condra, D.J. Holder, W.A. Schleif, O.M. Blahy, R.M. Danovich, and L.J. Gabryelski Genetic correlates of in vivo viral resistance to indinavir, a human immunodeficiency virus type 1 protease inhibitor J Virol 70 1996 8270 8276
-
(1996)
J Virol
, vol.70
, pp. 8270-8276
-
-
Condra, J.H.1
Holder, D.J.2
Schleif, W.A.3
Blahy, O.M.4
Danovich, R.M.5
Gabryelski, L.J.6
-
2
-
-
0028943992
-
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
-
J.H. Condra, W.A. Schleif, O.M. Blahy, L.J. Gabryelski, D.J. Graham, and J.C. Quintero In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors Nature 374 1995 569 571
-
(1995)
Nature
, vol.374
, pp. 569-571
-
-
Condra, J.H.1
Schleif, W.A.2
Blahy, O.M.3
Gabryelski, L.J.4
Graham, D.J.5
Quintero, J.C.6
-
3
-
-
0034639473
-
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy Trilege (Agence Nationale de Recherches sur le SIDA 072 Study Team)
-
D. Descamps, P. Flandre, V. Calvez, G. Peytavin, V. Meiffredy, and G. Collin Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy Trilege (Agence Nationale de Recherches sur le SIDA 072 Study Team) JAMA 283 2000 205 211
-
(2000)
JAMA
, vol.283
, pp. 205-211
-
-
Descamps, D.1
Flandre, P.2
Calvez, V.3
Peytavin, G.4
Meiffredy, V.5
Collin, G.6
-
4
-
-
0035823002
-
Drug resistance in patients experiencing early virological failure under a triple combination including indinavir
-
O. Gallego, C. de Mendoza, M.J. Perez-Elias, J.M. Guardiola, J. Pedreira, and D. Dalmau Drug resistance in patients experiencing early virological failure under a triple combination including indinavir AIDS 15 2001 1701 1706
-
(2001)
AIDS
, vol.15
, pp. 1701-1706
-
-
Gallego, O.1
De Mendoza, C.2
Perez-Elias, M.J.3
Guardiola, J.M.4
Pedreira, J.5
Dalmau, D.6
-
5
-
-
0034639490
-
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens
-
D.V. Havlir, N.S. Hellmann, C.J. Petropoulos, J.M. Whitcomb, A.C. Collier, and M.S. Hirsch Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens JAMA 283 2000 229 234
-
(2000)
JAMA
, vol.283
, pp. 229-234
-
-
Havlir, D.V.1
Hellmann, N.S.2
Petropoulos, C.J.3
Whitcomb, J.M.4
Collier, A.C.5
Hirsch, M.S.6
-
6
-
-
0038234808
-
Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel
-
M.S. Hirsch, F. Brun-Vezinet, B. Clotet, B. Conway, D.R. Kuritzkes, and R.T. D'Aquila Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel Clin Infect Dis 37 2003 113 128
-
(2003)
Clin Infect Dis
, vol.37
, pp. 113-128
-
-
Hirsch, M.S.1
Brun-Vezinet, F.2
Clotet, B.3
Conway, B.4
Kuritzkes, D.R.5
D'Aquila, R.T.6
-
7
-
-
1342289760
-
Drug resistance mutations in HIV-1
-
V.A. Johnson, F. Brun-Vezinet, B. Clotet, B. Conway, R.T. D'Aquila, and L.M. Demeter Drug resistance mutations in HIV-1 Top HIV Med 11 2003 215 221
-
(2003)
Top HIV Med
, vol.11
, pp. 215-221
-
-
Johnson, V.A.1
Brun-Vezinet, F.2
Clotet, B.3
Conway, B.4
D'Aquila, R.T.5
Demeter, L.M.6
-
8
-
-
0036090626
-
Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial)
-
V. Joly, P. Flandre, V. Meiffredy, F. Brun-Vezinet, J.A. Gastaut, and C. Goujard Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial) Antimicrob Agents Chemother 46 2002 1906 1913
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 1906-1913
-
-
Joly, V.1
Flandre, P.2
Meiffredy, V.3
Brun-Vezinet, F.4
Gastaut, J.A.5
Goujard, C.6
-
9
-
-
0002084094
-
Drug resistance testing: Time to be used in clinical practice
-
D. Kuritzkes Drug resistance testing: time to be used in clinical practice AIDS Rev 1 1999 45 50
-
(1999)
AIDS Rev
, vol.1
, pp. 45-50
-
-
Kuritzkes, D.1
-
10
-
-
0032704706
-
Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection
-
C. Lamotte, G. Peytavin, and R. Farinotti Determination of nelfinavir, a potent HIV protease inhibitor, and its active metabolite M8 in human plasma by high-performance liquid chromatography with photodiode-array detection J Chromatogr B Biomed Sci Appl 735 1999 159 170
-
(1999)
J Chromatogr B Biomed Sci Appl
, vol.735
, pp. 159-170
-
-
Lamotte, C.1
Peytavin, G.2
Farinotti, R.3
-
11
-
-
0033946694
-
Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: Virological evaluation of the AVANTI 2 and AVANTI 3 studies
-
M. Maguire, M. Gartland, S. Moore, A. Hill, M. Tisdale, and R. Harrigan Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies AIDS 14 2000 1195 2001
-
(2000)
AIDS
, vol.14
, pp. 1195-2001
-
-
Maguire, M.1
Gartland, M.2
Moore, S.3
Hill, A.4
Tisdale, M.5
Harrigan, R.6
-
12
-
-
0036174439
-
Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: Selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors
-
M. Maguire, D. Shortino, A. Klein, W. Harris, V. Manohitharajah, and M. Tisdale Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase nucleoside inhibitors Antimicrob Agents Chemother 46 2002 731 738
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 731-738
-
-
Maguire, M.1
Shortino, D.2
Klein, A.3
Harris, W.4
Manohitharajah, V.5
Tisdale, M.6
-
13
-
-
15444377672
-
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir
-
A. Molla, M. Korneyeva, Q. Gao, S. Vasavanonda, P.J. Schipper, and H.M. Mo Ordered accumulation of mutations in HIV protease confers resistance to ritonavir Nat Med 2 1996 760 766
-
(1996)
Nat Med
, vol.2
, pp. 760-766
-
-
Molla, A.1
Korneyeva, M.2
Gao, Q.3
Vasavanonda, S.4
Schipper, P.J.5
Mo, H.M.6
-
14
-
-
0033929132
-
Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance
-
M. Mouroux, A. Yvon-Groussin, G. Peytavin, C. Delaugerre, M. Legrand, and P. Bossi Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance J Clin Microbiol 38 2000 2726 2730
-
(2000)
J Clin Microbiol
, vol.38
, pp. 2726-2730
-
-
Mouroux, M.1
Yvon-Groussin, A.2
Peytavin, G.3
Delaugerre, C.4
Legrand, M.5
Bossi, P.6
-
15
-
-
0035003858
-
HIV-1 subtyping using phylogenetic analysis of pol gene sequences
-
C. Pasquier, N. Millot, R. Njouom, K. Sandres, M. Cazabat, and J. Puel HIV-1 subtyping using phylogenetic analysis of pol gene sequences J Virol Methods 94 2001 45 54
-
(2001)
J Virol Methods
, vol.94
, pp. 45-54
-
-
Pasquier, C.1
Millot, N.2
Njouom, R.3
Sandres, K.4
Cazabat, M.5
Puel, J.6
-
16
-
-
0032750954
-
Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies
-
E. Race, E. Dam, V. Obry, S. Paulous, and F. Clavel Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies AIDS 13 1999 2061 2068
-
(1999)
AIDS
, vol.13
, pp. 2061-2068
-
-
Race, E.1
Dam, E.2
Obry, V.3
Paulous, S.4
Clavel, F.5
-
17
-
-
0028896468
-
Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching
-
E. Woolf, T. Au, H. Haddix, and B. Matuszewski Determination of L-735 524, an human immunodeficiency virus protease inhibitor, in human plasma and urine via high-performance liquid chromatography with column switching J Chromatogr A 692 1995 45 52
-
(1995)
J Chromatogr a
, vol.692
, pp. 45-52
-
-
Woolf, E.1
Au, T.2
Haddix, H.3
Matuszewski, B.4
-
18
-
-
0035659914
-
Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir
-
S. Yerly, M. Rickenbach, M. Popescu, P. Taffe, C. Craig, and L. Perrin Drug resistance mutations in HIV-1-infected subjects during protease inhibitor-containing highly active antiretroviral therapy with nelfinavir or indinavir Antivir Ther 6 2001 185 189
-
(2001)
Antivir Ther
, vol.6
, pp. 185-189
-
-
Yerly, S.1
Rickenbach, M.2
Popescu, M.3
Taffe, P.4
Craig, C.5
Perrin, L.6
|